Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. The New York Times remembers Kent Campbell, the creator and first director of PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) program. Dr. Campbell is remembered for a legacy of lifesaving work over four decades in public health.
    Published: March 2024
  2. Despite their potential to shape public health outcomes, diagnostics have long been neglected and underfunded. PATH's Neeraj Jain proposes strategies to develop and advance connected diagnostic systems that are rooted in local contexts.
    Published: March 2024
  3. PATH’s Esther Nasikye speaks with Newzroom Afrika about the need for increased domestic financing for immunization and health programs in African countries.
    Published: February 2024
  4. After decades of research and development by PATH, GlaxoSmithKline, and other partners, the first doses of the RTS,S malaria vaccine began reaching children in Cameroon earlier this year.
    Published: February 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

946 Item s
946 Item s
    Date
    From
    To
  1. The CEPI-backed Research Preparedness Program in East and Central Africa aims to bolster regional clinical trial capacity and disease outbreak readiness.
    Published: March 2025
    Press Release
  2. Published: March 2025
    Announcement
  3. Results from a Phase 3 clinical study of Innovax’s WHO prequalified vaccine can help expand access globally and give countries another option for affordable, sustainable HPV vaccine.
    Published: March 2025
    Announcement
  4. The milestone marks the first-ever prequalification of an RSV vaccine and paves the way for improving respiratory disease prevention for infants around the world.
    Published: March 2025
    Statement
  5. The new Center enhances collaboration between PATH's technical and advocacy experts, boosting our ability to expand access to lifesaving health care through policy.
    Published: March 2025
    Press Release